Home >> Report Store >> Healthcare >> Biosimilars Market Analysis Size, Share & Industry Report, 2025 >

Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, and Recombinant Non-Glycosylated Proteins), By Application, and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

100+ Pages | Published Date : 30 / 07 / 17  | Report Code: AV134 | Report Format: PDF

REPORT HIGHLIGHT

The “Global Biosimilars Market- – Industry Analysis, Share, Trend, Market Size and Forecast” was estimated to be around US$ 4.59 billion in 2016 and is anticipated to grow with 35.7% of growth rate during the future period.

Market Dynamics

This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of branded drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.

Product Types Takeaway

In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period.

Application Takeaway

On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period. The rise in the aging population, increasing cancer patients, and rise of hospital acquired infection patients globally are factors responsible for the growth of this application segment.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment. The report aims at estimating the market size and future growth potential of market across different segments, such as product types, application and regions. The years considered for the study are:

  • Historical Year – 2014 & 2015
  • Base Year – 2015
  • Estimated Year – 2016
  • Projected Year – 2025

Companies reported in this report are: Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.

 TARGET AUDIENCE

  • Hospitals
  • Manufacturers
  • Traders, Distributors, And Suppliers of Biosimilars
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:

GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES

  • Recombinant Glycosylated Proteins
  • Recombinant Non-Glycosylated Proteins

GLOBAL BIOSIMILARS MARKET, BY APPLICATION

  • Oncology
  • Blood Disorders
  • Infectious Diseases
  • Autoimmune Diseases
  • Others

GLOBAL BIOSIMILARS MARKET, BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

GLOBAL BIOSIMILARS MARKET, GEOGRAPHIC ANALYSIS

  • Further Breakdown of The North America Biosimilars Market
    • U.S.
    • Canada
  • Further Breakdown of The Europe Biosimilars Market
    • Germany
    • France
    • Rest of Europe
  • Further Breakdown of The APAC Biosimilars Market
    • India
    • China
    • Rest of APAC
  • Further Breakdown of The Rest of the World Biosimilars Market
    • Middle East and Africa
    • Latin America
TABLE OF CONTENT

  1. BIOSIMILARS MARKET OVERVIEW
    • Study Scope
    • Base Year
    • Assumption and Methodology
  2. EXECUTIVE SUMMARY
    • Key Market Facts
    • Geographical Scenario
    • Companies in the Market
  3. BIOSIMILARS MARKETKEY MARKET TRENDS
    • Market Drivers
      • Impact Analysis of Market Drivers
    • Market Restraints
      • Impact Analysis of Market Restraints
    • Market Opportunities
    • Market Future Trends
  4. BIOSIMILARS MARKETINDUSTRY STUDY
    • Pipeline Therapeutic Analysis
    • Pricing Analysis
    • New Introduction by Leading Companies
  5. BIOSIMILARS MARKET LANDSCAPE
    • Market Share Analysis
    • Key Innovators
  6. BIOSIMILARS MARKET – BY PRODUCT TYPES:
    • Overview
    • Recombinant Glycosylated Proteins
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Recombinant Non-Glycosylated Proteins
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Recombinant Peptides
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. BIOSIMILARS MARKET – BY APPLICATION:
    • Overview
    • Oncology
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Blood Disorders
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Infectious Diseases
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Autoimmune Diseases
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Other Diseases
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. BIOSIMILARS MARKET– BY GEOGRAPHY
    • Introduction
    • North America
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • U.S.
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • Canada
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • Europe
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • France
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Germany
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Rest of Europe
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Asia Pacific (APAC)
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • China
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • India
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • Rest of APAC
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • Rest of the World
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
            • Latin America
              • Overview
              • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
            • Middle East and Africa
              • Overview
              • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. KEY VENDOR ANALYSIS
    • Astra Zeneca, plc
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Amgen, Inc.
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Pfizer, Inc.
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Biocon Ltd.
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Novartis AG
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Teva Pharma
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • STADA AG
      • Company Overview
      • SWOT Analysis
      • Key Developments
  1. 360 DEGREE ANALYSTVIEW
  2. APPENDIX
    • Research Methodology
    • Abbreviations
    • Disclaimer
    • Contact Us

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the Biosimilars Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the Biosimilars Market by its major segments, which include the type, end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the competitive landscape of this market
  • In-depth analysis of the key factors are propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow

KEY PREMIUM INSIGHTS:

  • Rising consumer wealth and income levels, increasing government and patient awareness, and a trend towards healthier lifestyles are anticipated to boost health care spending to around 8.1% in 2014-2018 in Asia Pacific
  • Biosimilars require high costs of investment and require a time frame to 7-8 years to enter the market
  • Economic expansion and government focus on broader welfare policies will drive the market for biosimilars.
RESEARCH METHDOLOGY

AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:

  • Official Company’s Website, Financial and Annual Reporting
  • Government Statistical Data
  • Online Publishing Articles
  • Industry Player’s Investor Presentations
  • Economic News Articles
  • National and International Trade Associations
  • The Financial, Business and Mainstream Press
  • Industry Study Groups and Other Semi-Official Sources
  • Many Other Informative Channels Related to the Market Topics
  • Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.

MARKET FORECAST

Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.

MARKET ANALYSIS

Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView?

 
Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.
Y

Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.
T

Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

 

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

 

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This